Canadian General Investments, Limited (CGRIF)
USD 29.07
(0.0%)
USD 29.07
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 8.63 Million | -4.68 Million | -2.07 Million | -722.91 Thousand | 3.18 Million | 2.6 Million |
| Net Income | 131.43 Million | -187.66 Million | 201.43 Million | 227.18 Million | 143.49 Million | -53.75 Million |
| Depreciation & Amortization | 74.71 Thousand | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 152.45 Thousand | -8.69 Million | 7.04 Million | -1.81 Million | 1.51 Million | -23.42 Thousand |
| Other non-cash items | -123.02 Million | 192.37 Million | -211.26 Million | -225.66 Million | -141.72 Million | 56.4 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -2.91 Million | -34.67 Million | -16.16 Million | -15.51 Million | 3.07 Million | -13.66 Million |
| Debt repayment | -75.47 Million | -18.44 Million | -570.02 Thousand | -447.4 Thousand | -18.11 Million | - |
| Dividends payments | -16.15 Million | -16.23 Million | -16.73 Million | -15.96 Million | -15.03 Million | -13.66 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -62.23 Million | -1.61 Million | -1.19 Million | -1.34 Million | -1.62 Million | - |
| Accounts receivables | 51.32 Thousand | -473.6 Thousand | 528.91 Thousand | -628.72 Thousand | -193.56 Thousand | -42.46 Thousand |
| Accounts payables | 148.63 Thousand | -233.11 Thousand | 189.74 Thousand | 189.95 Thousand | 91.76 Thousand | 21.96 Thousand |
| Inventory | - | - | 1.00 | - | - | - |
| Other working capital | 101.13 Thousand | -7.98 Million | 6.32 Million | -1.37 Million | 1.61 Million | -2928.69 |
| Cash at beginning of period | 2.65 Million | 13.12 Million | 5.44 Million | 16.22 Million | 50.89 Million | 4.68 Million |
| Cash at end of period | 8.43 Million | 2.65 Million | 13.12 Million | 5.44 Million | 16.22 Million | 50.89 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 5.77 Million | -10.46 Million | 7.68 Million | -10.78 Million | -34.66 Million | 46.2 Million |
| Free Cash Flow | 8.63 Million | -4.68 Million | -2.07 Million | -722.91 Thousand | 3.18 Million | 2.6 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 56.2 Million | 56.76 Million | 6.98 Million | 131.39 Million | 3.4 Million | 124.4 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -58.1 Thousand | -58.69 Thousand | 1.82 Million | 2.02 Million | -26.87 Thousand | 197.65 Thousand |
| Other non-cash items | -35.7 Million | -36.06 Million | -9.73 Million | -133.19 Million | 3.12 Million | -123.44 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -5.71 Million | -5.77 Million | -7.55 Million | 2.7 Million | -5.55 Million | 10.25 Million |
| Debt repayment | - | - | - | -18.86 Million | - | -18.86 Million |
| Dividends payments | -3.81 Million | -3.85 Million | -7.55 Million | -16.15 Million | -3.68 Million | -8.6 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.9 Million | -1.92 Million | -1.91 Million | -62.23 Million | -1.87 Million | 8.54 Million |
| Accounts receivables | -48.6 Thousand | -49.09 Thousand | -98.08 Thousand | 51.3 Thousand | -47.85 Thousand | 149.37 Thousand |
| Accounts payables | 69.41 Thousand | - | 15.08 Thousand | 148.63 Thousand | - | 133.52 Thousand |
| Inventory | - | - | 1.00 | - | - | - |
| Other working capital | -9501.47 | -9597.35 | 1.9 Million | 1.82 Million | 20.98 Thousand | -85.24 Thousand |
| Cash at beginning of period | 8.43 Million | - | 6.48 Million | 2.65 Million | - | 2.65 Million |
| Cash at end of period | 37.6 Million | 14.87 Million | 8.43 Million | 8.43 Million | 949.75 Thousand | 6.48 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 29.17 Million | 14.87 Million | 1.94 Million | 5.77 Million | 949.75 Thousand | 3.83 Million |
| Free Cash Flow | 20.44 Million | 20.64 Million | -1.01 Million | 432.32 Thousand | 6.5 Million | 1.44 Million |
PHYTO
DNN
SGMD
FN
ABBB
603323